Volume XXX, No. 14 – October 2, 2023
In this issue:
In the Oct. 2, 2023, issue of The Dark Report, we look at the Food and Drug Administration’s reasoning behind a proposed rule to more strictly regulate laboratory-developed tests. Other stories outline how the SALSA bill aims to combat PAMA cuts and what steps a clinical lab took to bring outreach services back in house.